Lawmakers seek passage of two bills that would help prevent, treat Alzheimer’s
By
Kimberly Bonvissuto
Nov 22, 2022
Two lawmakers are asking for support of two bipartisan bills to ensure the nation has the ability to continue both immediate and long-term planning in its battle against Alzheimer’s disease and related...
Dementia costs jump 31 percent in a decade, with care needs expected to grow
By
Alicia Lasek
Nov 02, 2022
Despite progress in risk reduction, testing and treatment, the costs of dementia care in the United States continue to rise alongside dementia prevalence, putting the onus on healthcare providers and other...
‘Significant’ drop in residential care aide workforce during pandemic raises questions about future...
By
Kimberly Bonvissuto
Sep 08, 2022
The residential care aide workforce — personal care aides, home health aides and nursing assistants who work in assisted living communities, continuing care retirement / life plan communities and other...
Feds’ antipsychotic drug reduction efforts in assisted living fail to produce success seen in nursing...
By
Alicia Lasek
Aug 23, 2022
A federal initiative to reduce antipsychotic prescribing in long-term care facilities failed to impact prescriptions in assisted living residents with dementia, the first study of its kind has found.
NIH requests additional $321M for Alzheimer’s, dementia research
By
Kimberly Bonvissuto
Aug 02, 2022
The National Institutes of Health has requested an additional $321 million in fiscal year 2024 for research into Alzheimer’s and other dementias.
Inverse link found for antioxidant levels, all-cause dementia
May 04, 2022
Serum lutein+zeaxanthin and β-cryptoxanthin levels were inversely associated with incident all-cause dementia.
Medicare will only cover Aduhelm for patients in clinical trials
Apr 08, 2022
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
Dementia to cost nation $321 billion this year, Alzheimer’s Association says
By
Kimberly Bonvissuto
Mar 16, 2022
This year, Alzheimer’s and other dementias will cost the nation $321 billion, increasing to $1 trillion by 2050, according to a report released Tuesday by the Alzheimer’s Association.
Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
One new law requires operators to provide tech for residents; another supports access to dementia screening...
By
Kimberly Bonvissuto
Oct 07, 2021
Assisted living operators in California will be required to provide video conferencing devices for residents under legislation signed into law on Monday. Another new law provides older adults in the Golden...